Ovid Therapeutics Inc (OVID)

$1.03 +0.07 (7.63%)
Market Cap 73.24M
Revenue (ttm) 570,000.00
Net Income (ttm) -26.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,636.84%
Debt to Equity Ratio 0.00
Volume 1,202,300
Avg Vol 2,062,912
Day's Range N/A - N/A
Shares Out 71.11M
Stochastic %K 90%
Beta 0.20
Analysts Strong Sell
Price Target $2.88

Company Profile

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 661 7661
Fax: 646 661 4027
Address:
441 Ninth Avenue, 14th Floor, New York, United States
Amcollins711
Amcollins711 Aug. 24 at 10:01 PM
$OVID https://finance.yahoo.com/news/lucid-capital-initiates-ovid-therapeutics-081220065.html Ovid Therapeutics Inc. (NASDAQ:OVID) is among the best US stocks under $10 to invest in. Analysts at Lucid Capital have begun coverage on Ovid Therapeutics Inc. (NASDAQ:OVID) with a Buy rating and a price target of $5.50, reflecting a potential surge of nearly 467% from the current price. Not sure I am going to find the entry point I was looking for after this news drop, $OVID is going to be on fire tomorrow
0 · Reply
BreakoutBull_
BreakoutBull_ Aug. 23 at 3:42 AM
$OVID Strong breakout entry today 🚀 Momentum looks strong — uptrend likely to continue. Follow for automatic breakout alerts!
0 · Reply
Amcollins711
Amcollins711 Aug. 22 at 7:53 PM
$OVID On my radar and I will be looking for a slight pull back for entry early next week
0 · Reply
Jtlo
Jtlo Aug. 22 at 3:57 PM
$OVID give us 10 days above one
0 · Reply
lucabrix
lucabrix Aug. 22 at 2:55 PM
$OVID yes its over, now the bull run!
0 · Reply
michaelhearn
michaelhearn Aug. 22 at 2:48 PM
$OVID not bearish anymore
0 · Reply
Winnning
Winnning Aug. 22 at 2:23 PM
$OVID LETS GOOOOO!!!!!!
0 · Reply
luccichio
luccichio Aug. 22 at 2:06 PM
$OVID
0 · Reply
BreakoutBull_
BreakoutBull_ Aug. 22 at 6:31 AM
$OVID Automatic Breakout zone updated! 🚀 Price breaks the zone — momentum building. Follow for simple, clear alerts.
0 · Reply
Zobzork
Zobzork Aug. 21 at 4:58 PM
$OVID opening small position
0 · Reply
Latest News on OVID
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results

Aug 13, 2025, 8:00 AM EDT - 11 days ago

Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference

Jul 23, 2025, 8:30 AM EDT - 4 weeks ago

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference

Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties

Jun 25, 2025, 8:00 AM EDT - 2 months ago

Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

May 13, 2025, 8:00 AM EDT - 3 months ago

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 8:00 AM EDT - 5 months ago

Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

Mar 3, 2025, 8:00 AM EST - 6 months ago

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 8:00 AM EST - 6 months ago

Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 5, 2025, 8:00 AM EST - 7 months ago

Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth

Sep 11, 2024, 8:00 AM EDT - 1 year ago

Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth

Shareholders In Ovid Therapeutics Inc Invited To Participate In Fraud Investigation With The Schall Law Firm

Aug 19, 2024, 11:00 AM EDT - 1 year ago

Shareholders In Ovid Therapeutics Inc Invited To Participate In Fraud Investigation With The Schall Law Firm

Ovid Therapeutics Inc Investors Encouraged To Join Fraud Investigation With Schall Law Firm

Aug 18, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Investors Encouraged To Join Fraud Investigation With Schall Law Firm

Ovid Therapeutics Inc Shareholders Eligible To Participate In Fraud Investigation With Schall Law Firm

Aug 17, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Shareholders Eligible To Participate In Fraud Investigation With Schall Law Firm

Ovid Therapeutics Inc Investors Invited To Join In Fraud Investigation With Schall Law Firm

Aug 16, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Investors Invited To Join In Fraud Investigation With Schall Law Firm

Ovid Therapeutics Inc Shareholders Encouraged To Join Fraud Investigation With Schall Law Firm

Aug 15, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Shareholders Encouraged To Join Fraud Investigation With Schall Law Firm

Ovid Therapeutics Inc Shareholders Invited To Join Fraud Investigation With Schall Law Firm

Aug 14, 2024, 10:30 PM EDT - 1 year ago

Ovid Therapeutics Inc Shareholders Invited To Join Fraud Investigation With Schall Law Firm

Ovid Therapeutics Inc Investors Welcome To Participate In Fraud Investigation With Schall Law Firm

Aug 14, 2024, 1:15 AM EDT - 1 year ago

Ovid Therapeutics Inc Investors Welcome To Participate In Fraud Investigation With Schall Law Firm

Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

Ovid Therapeutics Inc Investors Invited To Join Fraud Investigation With Schall Law Firm

Aug 12, 2024, 11:55 PM EDT - 1 year ago

Ovid Therapeutics Inc Investors Invited To Join Fraud Investigation With Schall Law Firm

Investors Of Ovid Therapeutics Inc Can Participate In Fraud Investigation With The Schall Law Firm

Aug 9, 2024, 9:15 PM EDT - 1 year ago

Investors Of Ovid Therapeutics Inc Can Participate In Fraud Investigation With The Schall Law Firm

Investors Of Ovid Therapeutics Inc Eligible To Join Fraud Investigation With The Schall Law Firm

Aug 8, 2024, 4:00 PM EDT - 1 year ago

Investors Of Ovid Therapeutics Inc Eligible To Join Fraud Investigation With The Schall Law Firm

Investors Of Ovid Therapeutics Inc Can Join Fraud Investigation With The Schall Law Firm

Aug 7, 2024, 11:30 PM EDT - 1 year ago

Investors Of Ovid Therapeutics Inc Can Join Fraud Investigation With The Schall Law Firm

Ovid Therapeutics Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Ovid Therapeutics Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

OVID Investors Have Opportunity to Join Ovid Therapeutics Inc. Fraud Investigation with the Schall Law Firm

Aug 2, 2024, 10:00 AM EDT - 1 year ago

OVID Investors Have Opportunity to Join Ovid Therapeutics Inc. Fraud Investigation with the Schall Law Firm

Ovid Therapeutics to Present at Upcoming August Investor Conferences

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at Upcoming August Investor Conferences

Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists

Jul 23, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists

Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations

Jul 1, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations

What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?

Jun 17, 2024, 8:58 AM EDT - 1 year ago

What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?

TAK

Ovid Therapeutics Reports on Takeda's Announcement of Phase 3 Topline Study Results for Soticlestat

Jun 17, 2024, 6:55 AM EDT - 1 year ago

Ovid Therapeutics Reports on Takeda's Announcement of Phase 3 Topline Study Results for Soticlestat

Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results

May 14, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results

Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 13, 2024, 7:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Ovid Therapeutics: Data Readouts For Rare Epileptic Indications Late 2024

Apr 9, 2024, 10:48 AM EDT - 1 year ago

Ovid Therapeutics: Data Readouts For Rare Epileptic Indications Late 2024

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Apr 4, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results

Mar 8, 2024, 8:00 AM EST - 1 year ago

Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results

Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

Feb 28, 2024, 8:00 AM EST - 1 year ago

Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Feb 6, 2024, 8:00 AM EST - 1 year ago

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)

Dec 1, 2023, 7:30 AM EST - 1 year ago

Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)

Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates

Nov 3, 2023, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026

Oct 18, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026

Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit

Oct 10, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit

Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023

Sep 26, 2023, 7:30 AM EDT - 2 years ago

Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023

Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

Sep 20, 2023, 7:30 AM EDT - 2 years ago

Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

Ovid Therapeutics to Participate in Upcoming September Investor Conferences

Aug 30, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics to Participate in Upcoming September Investor Conferences

Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates

Aug 4, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates

Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023

Aug 1, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023

Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer

Jun 28, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer

Amcollins711
Amcollins711 Aug. 24 at 10:01 PM
$OVID https://finance.yahoo.com/news/lucid-capital-initiates-ovid-therapeutics-081220065.html Ovid Therapeutics Inc. (NASDAQ:OVID) is among the best US stocks under $10 to invest in. Analysts at Lucid Capital have begun coverage on Ovid Therapeutics Inc. (NASDAQ:OVID) with a Buy rating and a price target of $5.50, reflecting a potential surge of nearly 467% from the current price. Not sure I am going to find the entry point I was looking for after this news drop, $OVID is going to be on fire tomorrow
0 · Reply
BreakoutBull_
BreakoutBull_ Aug. 23 at 3:42 AM
$OVID Strong breakout entry today 🚀 Momentum looks strong — uptrend likely to continue. Follow for automatic breakout alerts!
0 · Reply
Amcollins711
Amcollins711 Aug. 22 at 7:53 PM
$OVID On my radar and I will be looking for a slight pull back for entry early next week
0 · Reply
Jtlo
Jtlo Aug. 22 at 3:57 PM
$OVID give us 10 days above one
0 · Reply
lucabrix
lucabrix Aug. 22 at 2:55 PM
$OVID yes its over, now the bull run!
0 · Reply
michaelhearn
michaelhearn Aug. 22 at 2:48 PM
$OVID not bearish anymore
0 · Reply
Winnning
Winnning Aug. 22 at 2:23 PM
$OVID LETS GOOOOO!!!!!!
0 · Reply
luccichio
luccichio Aug. 22 at 2:06 PM
$OVID
0 · Reply
BreakoutBull_
BreakoutBull_ Aug. 22 at 6:31 AM
$OVID Automatic Breakout zone updated! 🚀 Price breaks the zone — momentum building. Follow for simple, clear alerts.
0 · Reply
Zobzork
Zobzork Aug. 21 at 4:58 PM
$OVID opening small position
0 · Reply
jeremy0916
jeremy0916 Aug. 21 at 3:09 PM
$OVID I want $1.50s
2 · Reply
Franzu
Franzu Aug. 21 at 9:54 AM
$OVID go go go go
0 · Reply
lucabrix
lucabrix Aug. 19 at 7:56 PM
$OVID nice green, correction could be over
0 · Reply
michaelhearn
michaelhearn Aug. 19 at 5:56 PM
$OVID of course it’s coiling
0 · Reply
algo888
algo888 Aug. 18 at 5:54 PM
$OVID support the pump on : DHAI all in @ .28
0 · Reply
SofaKing_Nuts
SofaKing_Nuts Aug. 18 at 5:13 PM
$OVID no worries. she'll walk back up
0 · Reply
lucabrix
lucabrix Aug. 18 at 3:16 PM
$OVID nice hammer coming in formation
0 · Reply
fruityfarmer
fruityfarmer Aug. 18 at 1:49 PM
$OVID good job shorts you stop loss me to a 70 dollar profit. I guess I'll play again tomorrow.now it will probably go the teens
0 · Reply
neueinvestor
neueinvestor Aug. 18 at 1:42 PM
$OVID what the fuck
0 · Reply
neueinvestor
neueinvestor Aug. 18 at 1:19 PM
$OVID
0 · Reply
fruityfarmer
fruityfarmer Aug. 18 at 11:42 AM
$OVID how high we going today???
2 · Reply
lucabrix
lucabrix Aug. 18 at 8:54 AM
$OVID Ride on track!!!
0 · Reply